These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 16807631)

  • 1. Homocysteine in vascular disease: an emerging clinical perspective.
    Jacobs P; Wood L; Bick R
    Cardiovasc J S Afr; 2006; 17(3):135-9. PubMed ID: 16807631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance.
    Boers GH
    Thromb Haemost; 1997 Jul; 78(1):520-2. PubMed ID: 9198207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperhomocysteinemia: a new independent vascular risk factor?].
    Cafagna D; Ponte E
    Minerva Cardioangiol; 1997; 45(1-2):49-55. PubMed ID: 9213816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperhomocysteinemia as a risk factor for vascular diseases].
    Ziegler R
    Med Monatsschr Pharm; 2006 Jun; 29(6):228-9. PubMed ID: 16792202
    [No Abstract]   [Full Text] [Related]  

  • 6. [Homocysteine, a risk factor of atherosclerosis].
    Ambrosi P; Rolland P; Garçon D
    Arch Mal Coeur Vaiss; 1996 Dec; 89(12):1667-71. PubMed ID: 9137733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine and endothelial function in human studies.
    Moat SJ; McDowell IF
    Semin Vasc Med; 2005 May; 5(2):172-82. PubMed ID: 16047269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Another genetic basis for vascular disease.
    Wadia RS
    Natl Med J India; 1992; 5(2):71-2. PubMed ID: 1304270
    [No Abstract]   [Full Text] [Related]  

  • 9. Higher incidence of C677T polymorphism of the MTHFR gene in North Indian patients with vascular disease.
    Bhargava S; Ali A; Parakh R; Saxena R; Srivastava LM
    Vascular; 2012 Apr; 20(2):88-95. PubMed ID: 22375042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk.
    Wang X; Keith JC; Struthers AD; Feuerstein GZ
    Cardiovasc Ther; 2008; 26(3):214-23. PubMed ID: 18786091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The homocysteinemia vascular risk factor. Methodologies and application to a clinical case].
    Garçon D; Barlatier A; Charpiot P; Calaf R; Joachim J; Perrin S; Habib M; Ambrosi P; Friggi A; Bodard H
    J Mal Vasc; 1991; 16(4):359-66. PubMed ID: 1791372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia and lower extremity wounds.
    Schwartzfarb EM; Romanelli P
    Int J Low Extrem Wounds; 2008 Sep; 7(3):126-36. PubMed ID: 18757388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy.
    Ueland PM; Refsum H
    J Lab Clin Med; 1989 Nov; 114(5):473-501. PubMed ID: 2681479
    [No Abstract]   [Full Text] [Related]  

  • 14. Vascular factors and depression.
    Teper E; O'Brien JT
    Int J Geriatr Psychiatry; 2008 Oct; 23(10):993-1000. PubMed ID: 18449953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteinemia: new information about an old risk factor for vascular disease.
    Engman M
    J Insur Med; 1998; 30(4):231-6. PubMed ID: 10537928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial responses to altered shear stress: pathologic implications for atherosclerosis.
    Chiu JJ; Usami S; Chien S
    Ann Med; 2009; 41(1):19-28. PubMed ID: 18608132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.
    Yap S; Naughten ER; Wilcken B; Wilcken DE; Boers GH
    Semin Thromb Hemost; 2000; 26(3):335-40. PubMed ID: 11011851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic mild hyperhomocysteinemia induces aortic endothelial dysfunction but does not elevate arterial pressure in rats.
    Miao CY; Villeneuve N; Brunel-Jacquemin C; Petit C; Guillaumin JP; Gransagne D; Briant C; Vilaine JP; Vanhoutte PM
    J Vasc Res; 2005; 42(2):148-56. PubMed ID: 15713986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction.
    Hassan A; Hunt BJ; O'Sullivan M; Bell R; D'Souza R; Jeffery S; Bamford JM; Markus HS
    Brain; 2004 Jan; 127(Pt 1):212-9. PubMed ID: 14607791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
    Tóth O; Dávid M; Habon T; Nagy A; Keszthelyi Z; Kovács N; Losonczy H
    Orv Hetil; 2005 Oct; 146(41):2121-5. PubMed ID: 16304806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.